Abnormal expression of NACC1 was shown to be linked to the poor prognostic features of many types of malignant tumors, such as ovarian cancer 28, 29, colorectal cancer 30, melanoma 31, 32, hepatocellular carcinoma 33 and other diseases. Here, NACC1 is linked to ovarian cancer.